Plasma trace elements, vitamin B12, folate, and homocysteine levels in cirrhotic patients compared to healthy controls

dc.contributor.authorHalifeoglu, I
dc.contributor.authorGur, B
dc.contributor.authorAydin, S
dc.contributor.authorOzturk, A
dc.date.accessioned2026-08-12T17:02:28Z
dc.date.issued2004
dc.departmentFırat Üniversitesi
dc.description.abstractIncreased serum homocysteine (Hcy) can induce liver diseases and can play a remarkable role in hepatic disorders. The purpose of the present study therefore was to investigate the relationship between serum vitamin B-12, folate, zinc and copper, cysteine, and Hcy level differences between cirrhotic patients and healthy subjects. We studied 32 cirrhotic patients (12 females and 20 males) aged 45 +/- 11 years and 32 control subjects (12 females and 20 males) aged 39 +/- 9 years. There was an inverse correlation between Hcy and vitamin B-12 in controls (r = -0.442, p < 0.011) but not in cirrhotic patients (r = -0.147, not significant). Also, mean plasma folate was decreased in cirrhotic patients compared to controls (p < 0.001). Copper increased whereas zinc decreased significantly in cirrhotic patients. A positive correlation was seen between the Cu/Zn ratio and Cu in controls (r = 0.690, p < 0.01), but the correlation between the Cu/Zn ratio and Cu was not significant in the cirrhotic group. Negative correlations were seen between plasma concentration of zinc and the Cu/Zn ratio in controls and cirrhotic patients (r = -0.618, p < 0.01 and r = -0.670, p < 0.01, respectively). Cirrhotic patients displayed multiple abnormalities, including changes in cysteine metabolism and in zinc and copper levels. Although hyperhomocysteinemia is known as an atherogenic and thrombogenic risk factor for cardiovascular disease, it might also be a risk factor for cirrhotic patients. Plasma Hcy, vitamin B-12, and folic acid measurement may be useful in the evaluation of cirrhotic patients.
dc.identifier.doi10.1023/B:BIRY.0000033744.32059.bd
dc.identifier.endpage696
dc.identifier.issn0006-2979
dc.identifier.issn1608-3040
dc.identifier.issue6
dc.identifier.orcid0000-0003-0787-0757
dc.identifier.pmid15236610
dc.identifier.scopus2-s2.0-3142741141
dc.identifier.scopusqualityQ2
dc.identifier.startpage693
dc.identifier.urihttps://doi.org/10.1023/B:BIRY.0000033744.32059.bd
dc.identifier.urihttps://hdl.handle.net/11508/48157
dc.identifier.volume69
dc.identifier.wosWOS:000222756000014
dc.identifier.wosqualityQ4
dc.indekslendigikaynakWeb of Science
dc.indekslendigikaynakScopus
dc.indekslendigikaynakPubMed
dc.language.isoen
dc.publisherPleiades Publishing Ltd
dc.relation.ispartofBiochemistry-Moscow
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı
dc.rightsinfo:eu-repo/semantics/closedAccess
dc.snmzKA_WoS_20260511
dc.subjectcirrhosis
dc.subjecthomocysteine
dc.subjectfolate
dc.subjectvitamin B-12
dc.titlePlasma trace elements, vitamin B12, folate, and homocysteine levels in cirrhotic patients compared to healthy controls
dc.typeArticle

Dosyalar